Remelox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Remelox

Property Description
Active Ingredient Meloxicam
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Chemical Subclass Oxicam Derivative
Origin Synthetic
Common Forms Tablet, Oral Suspension, Intravenous Solution

What Type of Medicine is Remelox (Meloxicam)?

Remelox is a medication containing the active ingredient Meloxicam, which is a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification means the drug is used to manage symptoms related to pain and inflammation by targeting key biological processes. Meloxicam is a synthetic compound and belongs to the oxicam derivative chemical subclass. It distinguishes itself within the NSAID group by being a preferential Cyclooxygenase-2 (COX-2) inhibitor, a mechanism that offers a degree of specificity in modulating the inflammatory response compared to non-selective NSAIDs.

Composition and Available Pharmaceutical Forms

The formulation of Remelox relies on Meloxicam as the sole active therapeutic component, confirming it as a single-ingredient product. This synthetic substance is made available in several pharmaceutical preparations to suit various medical needs and ensure flexible systemic delivery. Common forms include the standard oral tablet and the oral suspension (liquid form), which utilize the oral route of administration. Specialized forms, such as the intravenous solution for injection, are also available, enabling systemic delivery via the intravenous route when necessary.

General Therapeutic Purpose and Core Action

The fundamental purpose of Remelox is to provide effective symptomatic relief by reducing the severity of inflammation and the intensity of associated pain. Its core action limits the production of prostaglandins, which are lipid compounds that act as mediators of pain signaling and tissue swelling. This mechanism, driven by its COX-2 preferential inhibition, forms the basis of its general use, such as providing sustained comfort from stiffness. The consistent anti-inflammatory and analgesic effects demonstrated across its formulations have established its role as a recognized agent for managing inflammatory symptoms.

What side effects are possible with Remelox?

Possible Side Effects and Safety Information

The safety profile for Remelox (Meloxicam) is structured by governmental regulatory bodies to define the possible adverse reactions and associated risks. Adverse reactions are classified by frequency and grouped into System-Organ Classes (SOCs), such as Gastrointestinal Disorders and Nervous System Disorders.

Frequency-Classified Adverse Reactions

Side effects are officially reported in various incidence tiers:

Classification Examples of Documented Reactions
Very Common Dyspepsia
Common Headache, dizziness, diarrhea, abdominal pain, peripheral edema
Uncommon Anemia, vertigo, hypertension, gastrointestinal ulceration, rash, acute renal failure
Rare Gastrointestinal bleeding or perforation, hepatitis, severe skin reactions

Serious Adverse Reactions and Safety Constraints

The official labeling highlights several potential serious adverse reactions. These include the risk of Serious Cardiovascular Thrombotic Events, such as myocardial infarction and stroke, and Serious Gastrointestinal Adverse Events, including bleeding, ulceration, and perforation. The risk of these complications is documented as being more likely with increasing duration of use.

Safety constraints also apply to certain groups: Older adults are officially noted to be at a greater risk for serious gastrointestinal and renal adverse events. Meloxicam is officially contraindicated in the setting of coronary artery bypass graft (CABG) surgery and in individuals with a known history of hypersensitivity to the active substance or other NSAIDs.

Overdose and Emergency Response

Overdose and When to Seek Help

The information regarding Remelox (Meloxicam) overdose is strictly derived from official government regulatory documents.

Overdose may manifest with gastrointestinal distress, including epigastric pain, nausea, and vomiting. Central nervous system signs, such as lethargy and drowsiness, are also documented presentations.

Required Emergency Actions

The regulatory guidance mandates that individuals must seek immediate medical attention upon suspicion of an overdose. Contacting emergency services is necessary for severe or life-threatening manifestations, which may include acute renal failure, hepatic dysfunction, gastrointestinal bleeding, or systemic effects like coma and respiratory depression.

Management and Considerations

Management procedures described in regulatory sources for acute overdose focus on providing symptomatic and supportive treatment. For recent ingestion (typically within one hour), administration of activated charcoal or utilization of gastric emptying may be considered. No specific antidote is known for Meloxicam overdose. Due to the high risk of organ injury, continuous monitoring of vital signs and renal function is required. Official labeling notes that elderly patients and those with pre-existing renal impairment may be more susceptible to severe outcomes.

Therapeutic Uses of Remelox

Remelox is considered relevant for the symptomatic relief of painful symptoms related to inflammatory or irritative states. It is generally applied across domains where the goal is to manage distress and improve day-to-day comfort.

Remelox is indicated for relief of the signs and symptoms of Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Juvenile Idiopathic Arthritis (JIA) in patients aged two years and older.

The medication is commonly used across conditions characterized by periods of heightened symptoms, such as OA and RA. It helps address symptom clusters that interfere with daily comfort, including chronic stiffness, acute joint tenderness, and swelling. It is also applied in scenarios where additional management of discomfort is required, such as during episodes of increased distress or recurrent symptomatic manifestations, like menstrual cramps.

“Its use is relevant for helping to maintain symptomatic relief, which supports patients to cope more steadily with symptom fluctuations.”

This approach contributes to easing the overall symptom load and provides supportive relief when symptoms interfere with routine activities.

Quick Fact: Relief for Pain
Symptom Category: Symptoms related to inflammatory or irritative states.
Benefit Focus: Easing chronic stiffness and musculoskeletal pain.
Scenario Example: Long-term management of degenerative joint discomfort.

Eligibility and Restrictions for Use

Official Eligibility Profile for Remelox (Meloxicam)

Regulatory documents establish specific rules defining who can and cannot use Remelox, primarily based on contraindications, age, and pre-existing medical conditions.


Absolute Contraindications (Must Not Use)

Use of Remelox is strictly contraindicated in several patient groups due to high risk, including:

  • Patients with a known hypersensitivity to meloxicam or those who have had allergic-type reactions (like asthma or hives) after taking aspirin or other NSAIDs.
  • Patients requiring pain treatment following Coronary Artery Bypass Graft (CABG) surgery.
  • Pregnant women from 30 weeks gestation onward due to the risk of premature closure of the fetal ductus arteriosus.

Eligibility and Restricted Use

Population Group Eligibility Status (Regulatory Basis)
Age Approved for adults and children aged 2 years and older (for Juvenile Rheumatoid Arthritis only). Not approved for children under 2 years of age.
Organ Function Not recommended for patients with severe uncontrolled heart failure or advanced renal disease. Use is restricted in patients on hemodialysis.
Breastfeeding Use is generally not recommended due to unknown risk and lack of established data.

These limitations and contraindications are defined by governmental regulatory bodies (such as the FDA and EMA) and must be followed to ensure appropriate use.

What should I know about interactions with other medicines?

The official regulatory profile for Remelox details specific interaction patterns, primarily categorized by pharmacodynamic risk and effects on drug clearance.

Contraindicated Combinations and Restrictions

The medication is contraindicated for treating peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Co-administration is also prohibited for patients with a documented history of allergic-type reactions (such as asthma or urticaria) after taking aspirin or other NSAIDs. Furthermore, the oral suspension formulation carries a restriction against co-use with Sodium Polystyrene Sulfonate due to the potential for intestinal necrosis.

Pharmacokinetic and Exposure Modification

Remelox may significantly alter the plasma concentrations of certain co-administered drugs. Regulatory information indicates that it increases lithium plasma levels and may increase the toxicity of methotrexate by reducing its renal tubular secretion. Additionally, it may increase cyclosporine’s nephrotoxicity. The metabolism of meloxicam relies heavily on the CYP2C9 enzyme.

Pharmacodynamic Interactions and Efficacy

The co-administration of Remelox with warfarin or other anticoagulants may result in an increased risk of bleeding complications. The drug may also reduce the natriuretic effect of diuretics and diminish the antihypertensive effect of medicines such as ACE Inhibitors and ARBs. This interaction with blood pressure medications carries a specific caution regarding the deterioration of renal function in the elderly, volume-depleted, or renally impaired population. Ingestion of alcohol also increases the risk of serious GI adverse events.

Mechanism of Action

Targeting the COX-2 Enzyme to Modulate Eicosanoid Synthesis

Remelox (Meloxicam) operates within mechanistic domains that modulate biochemical messengers within the eicosanoid synthesis pathway. Its entire physiological profile stems from the targeted preferential inhibition of the Cyclooxygenase-2 ( COX-2) enzyme. COX-2 is responsible for synthesizing pro-inflammatory prostaglandins from arachidonic acid. By competitively blocking this enzyme, the drug directly reduces the local concentration of these potent lipid mediators, resulting in the physiological consequence of reduced local vascular permeability and edema.


Modulation of Nociceptive Signaling through Receptor Desensitization

The consequential decrease in prostaglandin E2 ( PGE2) levels directly impacts the peripheral nociceptive signaling pathway. PGE2 normally sensitizes nerve endings, making them hypersensitive to stimuli; therefore, its reduced presence increases the threshold for nociceptor activation. This modulation of nerve excitability influences signal propagation within the peripheral nociceptive pathway.


Central Adjustment of Thermoregulation

A secondary mechanistic domain involves COX inhibition within the hypothalamus in the central nervous system. This action suppresses the synthesis of PGE2 that mediates the deliberate elevation of the body's thermoregulatory set-point. This mechanism facilitates the reduction of the hypothalamic temperature set-point, resulting in the physiological consequence of decreased elevated body temperature.

Dosage and Administration Information

How Remelox is Used: Official Administration Guidelines

Remelox (Meloxicam) administration is governed by specific instructions defining the methods, frequencies, and limits of its use.

Administration Scope

Feature Official Instruction Summary
Route of Administration Approved for both the oral route (tablet, suspension) and the intravenous (IV) route (injection).
Dosing Schedule The standard adult oral dose begins at 7.5 mg once daily, with a maximum of 15 mg once daily. The IV dose is 30 mg once daily.
Frequency The total daily amount is administered once daily across all approved routes and indications.
Timing in Relation to Meals Oral tablets may be taken without regard to the timing of meals, though some instructions advise intake with food and liquid.

Procedural and Population-Specific Rules

The usage protocol is defined by procedural and population-based constraints to ensure standardized administration:

  • Pediatric Dosing (JIA): For patients aged two years and older with Juvenile Idiopathic Arthritis (JIA), the oral dose is calculated at 0.125 mg/kg once daily, not to exceed 7.5 mg daily.
  • Special Administration: The IV solution must be administered as an intravenous bolus injection over a minimum of 15 seconds. Patients must be well hydrated prior to IV use.
  • Population Limits: A lower maximum oral daily dose of 7.5 mg is specified for patients undergoing hemodialysis.

Overall Protocol Structure

The official use protocol is structured around a mandatory once-daily schedule and strict adherence to the maximum daily dose. This protocol includes specific administration techniques, such as the IV bolus timing, and defines necessary dose modifications for certain populations, all based on procedural instruction.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Remelox

The clinical evaluation of Remelox (meloxicam) was observed in research exploring outcomes related to physical discomfort and systemic imbalance linked to inflammatory or irritative states. The evidence base is derived from controlled clinical trials and systematic scientific reviews, which are relevant in evidence describing how symptoms are measured and how they change during defined study periods.

Evidence for Use in Osteoarthritis (OA)

The research exploring Remelox was evaluated in short-term randomized controlled trials (RCTs). These studies was observed in comparison with an inactive substance (placebo) or with other active treatments. The trials was observed in adult populations, including older adults, diagnosed with OA.

In these trials, research examined outcomes related to physical discomfort. Studies report how symptoms evolved in the observed populations, measuring changes in the assessed markers of physical discomfort over study periods that typically lasted up to six months. Findings describe group patterns, not personal outcomes, and follow-up durations for core efficacy trials were limited relative to the long-term nature of OA.

Evidence for Use in Rheumatoid Arthritis (RA)

Remelox was studied for use in patients with Rheumatoid Arthritis in controlled trials involving adult patients with active disease. These studies explored outcomes reflecting daily functioning and systemic imbalance. They tracked specific changes in disease activity using recognized clinical measures, such as the ACR20 response criteria, which describes patterns related to consistency across multiple symptoms. Studies monitored outcomes related to systemic imbalance and described patterns of change in acute signs and symptoms. Studies were limited to observation periods typically up to six months, and there is limited information for long-term outcomes.

Evidence in Pediatric Juvenile Idiopathic Arthritis (JIA)

Remelox was studied for patients aged two years and older with certain subtypes of Juvenile Idiopathic Arthritis. The research strategy involved specialized clinical trials, often comparing Remelox to another active treatment option. These studies specifically examined patient-reported outcomes describing perceived discomfort in children. The volume of evidence is smaller and more specialized compared to adult arthritis research, and the results apply only to the populations studied.

Key Research Gaps and Uncertainties

The evidence base studies contribute to the broader evidence landscape, and research does not determine whether an individual will respond similarly to the group patterns observed. Evidence highlights that the studies are focused entirely on symptomatic relief, and the data provides no insight into whether the medication alters the underlying structural progression of conditions like OA or RA.

Key Studies & References

  1. Systematic review and network meta-analysis of different non-steroidal anti-inflammatory drugs for juvenile idiopathic arthritis

Frequently Asked Questions (FAQ)

Common questions about Remelox (FAQ)


Q: Is Remelox the same as [Common Similar Drug Name]?

Remelox contains the active ingredient Meloxicam, which is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and belongs to the oxicam derivative chemical subclass. Official documents rely on this specific classification to distinguish it from other pain and inflammation medicines.


Q: Is Remelox considered safe for long-term use?

Official information indicates that the risk of serious adverse events may increase with the duration of use. Specifically, the risk of serious cardiovascular thrombotic events and gastrointestinal bleeding or ulceration is noted to be more likely with longer periods of treatment.


Q: Is Remelox safe for older adults (seniors)?

Regulatory documents state that older adults are officially listed as being at a greater risk for experiencing serious gastrointestinal and kidney-related adverse events compared to younger individuals. Regulatory documents also outline specific dose modifications for certain populations, such as those undergoing hemodialysis.


Q: Can Remelox be taken by people with kidney issues?

The official labeling states that the use of Remelox is not recommended for patients who have advanced kidney disease, unless the expected benefits are determined to outweigh the potential risks of worsening kidney function. Specific dose modifications are outlined for populations like those undergoing hemodialysis.


Q: Does taking Remelox affect blood pressure?

Official safety information indicates that Remelox can cause the new onset or worsening of high blood pressure (hypertension). The labeling indicates that monitoring blood pressure is part of the required protocol during treatment.


Q: Can Remelox interact with common pain relievers like ibuprofen or Tylenol?

The official label strongly advises against combining Remelox with aspirin or other NSAIDs (such as ibuprofen) due to an increased risk of serious gastrointestinal events. Caution is also advised regarding combining it with acetaminophen ( Tylenol), due to the potential for increased GI issues.


Q: Are there any specific warnings about Remelox for children or teenagers?

The medication is approved for use in children aged 2 years and older, but only for the relief of symptoms related to Juvenile Rheumatoid Arthritis ( JIA). It is strictly not approved for use in children under the age of two, and certain formulations are contraindicated for children below 12 years of age.


Q: Does Remelox have a 'Black Box Warning' from the FDA?

Yes, the FDA has issued a Boxed Warning, which is a key safety constraint in the regulatory labeling. This warning highlights the risk of serious cardiovascular thrombotic events (such as heart attack or stroke) and serious gastrointestinal events (including bleeding, ulcers, and perforation).


Q: What is the average duration of treatment with Remelox?

Regulatory information advises that the medication should be used at the lowest effective daily amount for the shortest duration possible. This approach is recommended to align with individual treatment goals while minimizing potential risks associated with the medication.


Q: What is Remelox's effect on driving or operating machinery?

Adverse event reports list dizziness and headache as common side effects, with vertigo being an uncommon effect. Due to the potential for these central nervous system effects, caution is advised regarding activities requiring mental alertness, such as driving or operating machinery.


Q: What is Remelox used for besides the main condition?

Approved uses for Remelox, as listed in the official indications, include the relief of the signs and symptoms of Osteoarthritis ( OA), Rheumatoid Arthritis ( RA), and Juvenile Rheumatoid Arthritis ( JIA) in patients aged two years and older.


Q: How quickly should someone expect to feel the effect of Remelox?

For the chronic inflammatory conditions it is used to treat, the full clinical benefit can require 1 to 2 weeks of continuous, regular daily use to become noticeable. The official documentation notes the distinction in onset time between the oral and intravenous forms of the medication.


Q: How long does Remelox stay in your system?

The drug’s elimination half-life is approximately 20 hours. Steady-state plasma concentrations, where the drug maintains a stable level in the body, are typically achieved within 3 to 5 days of continuous daily administration.


Q: Can Remelox cause weight gain or weight loss?

Fluid retention ( edema) is noted as a common side effect of Remelox in official documents. Unexplained weight gain is also listed as a symptom associated with the serious adverse reactions of heart failure or liver damage, which require careful observation.


Q: Is it normal to feel tired when starting Remelox?

Fatigue, which is the experience of unusual tiredness or lack of energy, is listed as a possible side effect in post-marketing adverse reaction reports. This suggests it is an effect that some users may experience.


Q: Does Remelox affect sleep or cause insomnia?

Insomnia, defined as difficulty falling asleep or staying asleep, is listed in post-marketing experience reports as a potential adverse effect associated with the medication.


Q: Can you drink coffee or caffeine while taking Remelox?

Official information does not list caffeine as a specific contraindication. However, combining caffeine with an NSAID like Remelox may increase the potential for gastrointestinal irritation and ulcers.


Q: What happens if you miss a dose of Remelox?

Official patient instructions state that if a dose is missed, the medication may be taken as soon as remembered. If it is almost time for the next scheduled dose, the regulatory protocol is to skip the missed dose and resume the normal dosing schedule. The instructions note that taking two doses at the same time to compensate for a missed dose is not advised.


Q: Is Remelox safe for people who have liver problems?

Remelox has the potential to cause hepatotoxicity ( liver damage). Regulatory documents indicate that use by patients with pre-existing liver dysfunction requires caution, and monitoring for abnormal liver enzyme levels is part of the safety protocol.


Q: Is there a generic version of Remelox available?

Remelox is a brand name for the active ingredient Meloxicam. Generic versions of Meloxicam tablets and suspensions are available, which contain the same active therapeutic component.


Q: Is Remelox addictive or habit-forming?

The active ingredient in Remelox, Meloxicam, is not classified as a controlled substance by regulatory bodies. It is not generally considered to be addictive or habit-forming.


Q: Can Remelox be cut in half or crushed?

The official product information notes that a score line on some tablets is intended only to facilitate swallowing, not to divide the dose equally. The regulatory protocol specifies that certain formulations, such as orally disintegrating tablets, must not be cut, crushed, or chewed.


Q: How is Remelox eliminated from the body?

The drug is processed and converted into inactive byproducts in the liver, primarily using the CYP2C9 and CYP3A4 enzymes. These inactive metabolites are then cleared from the body through the urine (kidneys) and the faeces in roughly equal amounts.


Q: Can Remelox cause changes in mood or anxiety?

Anxiety and mild depression are listed as potential adverse effects in the post-marketing adverse reaction reports associated with the medication. These are central nervous system effects that have been reported by some users.


Q: Can Remelox interact with vitamins or herbal supplements?

The official label advises caution when starting new medicines or supplements. This is because some herbal products, particularly those that are known to affect blood clotting, may increase the existing risk of bleeding associated with the use of Remelox.


Q: Can Remelox cause hair loss?

Thinning hair has been listed as a potential side effect in some post-marketing adverse reaction reports. This suggests it is a reported, though not commonly occurring, effect.


Q: What is the shelf life of Remelox tablets?

The specific shelf life is determined by the manufacturer and is noted on the packaging. All forms of the medication must be stored at Controlled Room Temperature, specifically between 20 C and 25 C. The container should be kept tightly closed and protected from light.


Q: Does Remelox contain gluten or lactose?

The inactive ingredients ( excipients) contained in the tablets or liquid vary based on the specific formulation and the manufacturer. The full list of ingredients should be checked in the official Medication Guide or patient leaflet.


Q: What kind of monitoring (like blood tests) is generally described as necessary with Remelox?

The official labeling recommends clinical monitoring of several body functions during treatment. This monitoring may include checking blood pressure, renal function (kidneys), hepatic function (liver), and observing for signs or symptoms of anemia or gastrointestinal bleeding.

How should Remelox be stored and disposed of?

How to Store and Dispose of Remelox?

Remelox (meloxicam) requires specific storage and disposal practices to ensure its stability and safe handling.

Storage Requirement Official Classification
Temperature Store at Controlled Room Temperature (20°C to 25°C or 68°F to 77°F), allowing excursions between 15°C and 30°C.
Container & Protection Keep the container tightly closed and protect from light.
Handling The oral suspension form should be shaken gently before using.

Disposal Instructions:

  • Keep out of reach of children at all times.
  • Remelox is not on the FDA's list of medicines recommended for flushing down the toilet.
  • If a drug take-back program is unavailable, dispose of it in the household trash. First, mix the medicine with an undesirable substance (such as dirt, cat litter, or used coffee grounds), and then place the mixture in a sealed bag or container before discarding it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Remelox found in:

A-Z Index: